World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02304471
Date of registration: 26/11/2014
Prospective Registration: No
Primary sponsor: National Taiwan University Hospital
Public title: Circulating lncRNA and CV Morbidities in CKD and ESRD
Scientific title: Circulating Long Non-coding RNAs and Cardiovascular Morbidities in Chronic Kidney Disease and End-Stage Renal Disease
Date of first enrolment: November 2014
Target sample size: 360
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02304471
Study type:  Observational
Study design:  Observational Model: Case Control, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Taiwan
Contacts
Name:     Chun-Fu Lai, M.D.
Address: 
Telephone: +886-2-23123456
Email: s821052@gmail.com
Affiliation: 
Name:     Chun-Fu Lai, M.D.
Address: 
Telephone:
Email:
Affiliation:  National Taiwan University Hospital
Name:     Chun-Fu Lai, M.D.
Address: 
Telephone: +886-2-23123456
Email: s821052@gmail.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- 1.Adult patients with various stages 1-5 of CKD will be enrolled at outpatient
clinic. Definition and staging of CKD were defined by estimated glomerular filtration
rate by the Modification of Diet in Renal Disease study equation.

- 2.Patients with ESRD under maintenance hemodialysis or peritoneal dialysis will also
be included.

Exclusion Criteria:

- 1.age younger than 20 years or older than 80 years.

- 2.pregnant woman.

- 3.patients already received kidney transplantation.

- 4.recent hospitalization within previous one month.

- 5.for ESRD patients, receiving maintenance hemodialysis or peritoneal dialysis for
less than 3 months.



Age minimum: 20 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
End-stage Renal Disease
Chronic Kidney Disease
Intervention(s)
Primary Outcome(s)
Adverse cardiovascular events (acute myocardial ischemia, life-threatening atrial/ventricular arrhythmias, acute decompensated heart failure, stroke and cardiovascular death) [Time Frame: 3 years]
Secondary Outcome(s)
Secondary ID(s)
201409019RINB
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history